Asset Management One Co., Ltd. Krystal Biotech, Inc. Transaction History
Asset Management One Co., Ltd.
- $31.2 Billion
- Q2 2025
A detailed history of Asset Management One Co., Ltd. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 617 shares of KRYS stock, worth $85,553. This represents 0.0% of its overall portfolio holdings.
Number of Shares
617Holding current value
$85,553% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
332Shares Held
24.4MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$547 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$392 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$379 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$170 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$132 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.56B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...